U.S. Pharma Stock News

Wondering if Ford Motor's stock is still a value play after its big run, or if you have already missed the sweet spot? This breakdown will help you decide whether it deserves a place in your portfolio. Ford is trading at $13.47 after slipping 1.3% over the last week, but that comes on the back of a 5.0% gain over the past month, a 39.6% jump year to date, and a 46.1% rise over the last year, nearly doubling over 5 years with a 99.7% total return. Recent headlines have focused on Ford's...

Workiva announced that Barbara Larson will become Chief Financial Officer and Executive Vice President in January 2026, with CEO Julie Iskow serving as interim CFO and Treasurer from late December 2025 until Larson assumes the role. This leadership transition brings in a finance executive with experience at SentinelOne, Workday, VMware, TIBCO, Symantec, and Equifax’s board, as Workiva pursues global growth and broader adoption of its AI-powered reporting platform. Next, we’ll examine how...

RXO (RXO) is back in focus after a string of cautious analyst updates and a negative outlook revision from S&P Global, all pointing to the same issue: margin pressure is getting harder to ignore. See our latest analysis for RXO. The market has been quick to price in those tightening margins, with RXO’s 7 day share price return of minus 9.6 percent and a year to date share price return of minus 42.7 percent underscoring fading momentum despite a recent 30 day share price rebound of 18.2...

Old National Bancorp (ONB) just pulled investors into a legal drama by suing Bell Bank and eight former employees over alleged coordinated resignations, trade secret misuse, and customer poaching at key Minnesota branches. See our latest analysis for Old National Bancorp. At around $23.35, Old National’s recent momentum looks constructive, with a 1 month share price return of 10.66 percent and a 1 year total shareholder return of 10.57 percent suggesting investors are cautiously rewarding its...

In its recently reported third quarter, Federated Hermes posted revenue growth of 14.9% year on year, beating analyst estimates by 5.5% and delivering a stronger-than-expected earnings performance. This upside surprise was powered by record net sales of equity funds and rising demand for the firm’s MDT equity and alternative quantitative strategies, underscoring investor appetite for its quantitative capabilities. Next, we’ll examine how this earnings beat, underpinned by record equity fund...

Cytokinetics has secured U.S. FDA approval for MYQORZO (aficamten) tablets to treat adults with symptomatic obstructive hypertrophic cardiomyopathy, its first approved medicine and one that comes with a boxed warning and a REMS program due to heart failure risk. The label’s flexible dosing, lack of mandatory drug–drug interaction monitoring, and supporting Phase 3 SEQUOIA-HCM data could meaningfully influence how cardiologists position MYQORZO against existing therapies in oHCM care. We’ll...

Bausch Health Companies Inc. has reported past results of its exchange offers, with Existing Senior Secured Notes tendered for up to US$1.60 billion in new 10.00% Senior Secured Notes due 2032 issued by subsidiary 1261229 B.C. Ltd. The very large US$2.69 billion of notes submitted by the early tender time highlights strong creditor participation in reshaping Bausch Health’s debt profile. We’ll now examine how this large-scale debt exchange, especially extending maturities to 2032, feeds into...

Joby Aviation (JOBY) has quietly traded higher this month, and that move is getting harder for investors to ignore. With shares up about 9% in the past month and 76% year to date, the market is clearly reassessing its long term air taxi story. See our latest analysis for Joby Aviation. That surge sits within a much bigger move, with a roughly 76% year to date share price return and an even stronger 3 year total shareholder return above 300%. This suggests momentum is building as investors...

Southern (SO) just secured a major green light in Georgia, where regulators unanimously approved Georgia Power’s plan to boost capacity to meet the AI-driven data center surge across the state. See our latest analysis for Southern. Despite the regulatory win, Southern’s recent share price return has cooled, with a roughly 9 percent 3 month pullback and softer 1 month performance, even as its 5 year total shareholder return of about 72 percent signals durable, long term compounding. If this AI...

Earlier this month, Revvity, Inc. introduced Signals Xynthetica, an AI Models-as-a-Service offering within its Revvity Signals platform to support AI-augmented molecular and materials design by unifying in-silico generation, predictive modeling, and experimental validation in a governed environment. An interesting angle is that Signals Xynthetica embeds AI models directly into real-world lab workflows, linking predictions with wet-lab outcomes to create a continuously learning discovery loop...

As the U.S. market experiences a resurgence with major stock indexes closing sharply higher for the second consecutive day, small-cap stocks are gaining attention amid this renewed risk appetite. In this dynamic environment, identifying promising small-cap opportunities involves looking at companies with solid fundamentals and potential growth catalysts that align well with current market trends.

J.B. Hunt Transport Services (JBHT) heads into its upcoming Q4 earnings with expectations running higher than usual, following a strong Q3 and a clear uptick in bullish options activity around the stock. See our latest analysis for J.B. Hunt Transport Services. The strong Q3 surprise and recent bullish options flow have helped fuel a sharp rebound. J.B. Hunt’s roughly 50 percent 3 month share price return signals that momentum is clearly building rather than fading. If this kind of move has...

OceanFirst Financial (OCFC) just picked up a cluster of upbeat analyst calls, with DA Davidson and Keefe, Bruyette & Woods upgrading their views while Raymond James reiterated its strong buy stance. See our latest analysis for OceanFirst Financial. Those bullish calls are landing as OceanFirst’s share price holds near $20.12, with a 1 month share price return of 10.55 percent and a 5 year total shareholder return of 30.78 percent, suggesting momentum is quietly rebuilding around the story. If...

As the U.S. market experiences a resurgence in tech stocks, with key indices like the S&P 500 and Nasdaq posting gains amid renewed investor confidence, attention turns to high-growth opportunities within the tech sector. In this environment, identifying promising stocks involves looking for companies that demonstrate robust innovation and adaptability to capitalize on emerging trends such as AI and cloud computing.

As the U.S. stock market experiences a resurgence with major indexes posting gains, driven by a rally in tech stocks, investors are increasingly looking for opportunities that may be undervalued. In this environment of renewed risk appetite and shifting sector performances, identifying stocks that offer strong fundamentals at attractive valuations becomes crucial for those seeking potential value in their portfolios.

Recent findings from Ramsey Theory Group highlight a critical juncture for enterprise software as the industry grapples with the rapid adoption of AI amid significant integration challenges, cybersecurity risks, and data migration complexities. The report outlines concerns that these converging forces could lead to operational inefficiencies and increased enterprise risks if not addressed. With AI demand outpacing many organizations' readiness to integrate systems and secure data effectively,...

Coherent Corp. ( NYSE:COHR ) shares have continued their recent momentum with a 33% gain in the last month alone. The...

As the U.S. stock market experiences a resurgence, with major indexes like the S&P 500 and Nasdaq posting weekly gains amid a tech rally, investor confidence appears to be on the rise. In such an environment, growth companies with high insider ownership can signal strong internal belief in their long-term potential, making them attractive considerations for those looking to align with management's vision.

As of December 19, 2025, major stock indexes in the United States have shown a notable upswing, with the tech-heavy Nasdaq and benchmark S&P 500 posting weekly gains amid a continued rally in technology shares. This positive momentum in broader markets can create an intriguing backdrop for exploring investment opportunities across various sectors. Penny stocks, while often considered speculative due to their lower price points and smaller company profiles, remain relevant as they can offer...

As December 2025 unfolds, the United States stock market is experiencing a notable upswing, with major indexes like the S&P 500 and Nasdaq posting weekly gains driven by a renewed tech rally. This positive momentum highlights the potential for small-cap stocks to shine, especially those that are well-positioned to capitalize on evolving economic conditions and investor sentiment.

As the U.S. stock market experiences a resurgence with major indexes like the S&P 500 and Nasdaq posting weekly gains, investors are increasingly eyeing dividend stocks as a way to capture steady income amid fluctuating tech sector performances. In this environment, selecting dividend stocks that offer yields between 4% and 5.1% can provide both reliable returns and potential for capital appreciation, making them attractive options in today's dynamic market landscape.

In the last year, multiple insiders have substantially increased their holdings of Repay Holdings Corporation...

Key Insights Insiders appear to have a vested interest in Freedom Holding's growth, as seen by their sizeable ownership...

Alto Ingredients, Inc. ( NASDAQ:ALTO ) shares have continued their recent momentum with a 41% gain in the last month...